Author:
Miller Megan E.,Nielsen Sarah M.,Kulkarni Swati A.
Reference95 articles.
1. National Comprehensive Cancer Network. Genetic/familial high-risk assessment: breast and ovarian cancer. NCCN Clinical Practice Guidelines in Oncology. NCCN.org, 2011.
2. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117–30.
3. Finch A, Beiner M, Lubinski J, et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA. 2006;296:185–92.
4. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302:643–6.
5. Reis LAGKC, Hankey BF, Miller BK, editors. SEER cancer statistics review, 1973–1995. Bethesda, MD: National Cancer Institute; 1998.